On Assignment, Inc. (ASGN)

Check out top investors' recommendation for ASGN
Last closing price (N/A)
(0.00%) ? 
Last closing price is the stock price upon last market close (date specified in parenthesis).
Return to date (1m/3m/6m/12m):
N/A ? 
Return to date is the stock return for the specified period of time.
Consensus price target (1m/3m/6m/12m):
59.67
 ? 
Consensus price target is the average analyst price target for a specified period of time.
Buy/Sell Mix (1m/3m/6m/12m):
100%/0%
 ? 
Buy/sell mix the percentage mix between Buy and Sell recommendations for a given company or a research firm. Hold recommendations are excluded.
Description:
On Assignment, Inc., a diversified professional staffing firm, provides short- and long-term placement of contract, contract-to-hire, and direct hire professionals in the United States, Europe, Canada, China, Australia, and New Zealand. The company operates in five segments: Apex, Oxford, Life Sciences, Healthcare, and Physician. The Apex segment provides mission-critical information technology (IT) operations professionals for contract, contract-to-hire, and permanent placement positions to Fortune 1000 and mid-market clients. It serves companies from industries, including financial services, business services, consumer and industrials, technology, healthcare, government services, and communications. The Oxford segment provides high-end contract and direct placement services of IT and engineering professionals in the specialized IT; software and hardware engineering; and mechanical, electrical, validation, and telecommunications engineering fields. The Life Sciences segment offers contract, contract-to-permanent, and direct placement services of laboratory and scientific professionals to the biotechnology, pharmaceutical, food and beverage, medical device, personal care, chemical, and environmental industries. Its contract staffing specialties include chemists, clinical research associates, clinical lab assistants, engineers, biologists, biochemists, microbiologists, molecular biologists, food scientists, regulatory affairs specialists, lab assistants, and other scientific professionals. The Healthcare segment provides professionals, such as nurses, specialty nurses, respiratory therapists, surgical technicians, imaging and X-ray technicians, medical technologists, phlebotomists, coders, billers, claims processors, and collections staff. The Physician segment offers contract and direct placement physicians in hospitals; community-based practices; and federal, state, and local facilities. The company was founded in 1985 and is headquartered in Calabasas, California.
Sector:
Analyst
An analyst is a professional research analyst or an Investor Wand user who issued a recommendation for a given company.
Research Firm
A Research Firm is a company that researches and rates stocks and publishes recommendations.
Signal
Signal is a recommendation issued by an analyst. Investor Wand considers two types of recommendations: BUY and SELL.
Signal Date
A signal date is a date when a BUY or SELL recommendation was issued for given security.
Initial Price
Initial Price is the first closing price for a specified company upon recommendation release. If the recommendation is issued in after-market hours, the Initial Price is the next day’s closing price (for a given symbol). In case of dividend distributions and stock splits, Initial Price is adjusted.
Price Target
A Price Target is an analyst’s projection of a company’s stock price by the end of the recommendation period. It represents the price at which the analyst would exit his or her existing position.
Closing Date
Closing Date is the expiration date of a recommendation. The validity timeframe of a professional analyst’s recommendation is 12 months. Investor Wand analysts can set their recommendation timeframe to one, three, six, or 12 months.
Return
The return on a single open recommendation is calculated as the maximum of the current return (based on the latest closing price) and the target price return, if the symbol reached the target. The return on a single closed recommendation is calculated as the maximum of the return on the closing date (at the end of recommendation timeframe) and the target price return, if the stock hit the target price. The return is adjusted for one-time events (e.g., stock splits).
Gary Bisbee Barclays Buy   Oct 26, '17     61.00  Oct 26, '18  N/A 
Jeffrey Silber BMO Capital Markets Buy   Oct 08, '17     59.00  Oct 08, '18  N/A 
Jeffrey Silber BMO Capital Markets Buy   Sep 01, '17     59.00  Sep 01, '18  N/A 
Jeffrey Silber BMO Capital Markets Buy   Jul 11, '17     60.00  Jul 11, '18  N/A 
Randle Reece Avondale Partners LLC Buy   Feb 15, '17       Feb 15, '18  N/A 
Gary Bisbee Barclays Buy   Jan 20, '17     51.00  Jan 20, '18  N/A 
Jeffrey Silber BMO Capital Markets Buy   Sep 07, '16     45.00  Sep 07, '17  N/A 
Randle Reece Avondale Partners LLC Buy   Apr 28, '16     45.00  Apr 28, '17  N/A 
Randle Reece Avondale Partners LLC Buy   Feb 18, '16   32.95  39.00  Feb 18, '17  47.80% 
Gary Bisbee Barclays Buy   Feb 18, '16   32.95  46.00  Feb 18, '17  47.80% 
George Tong Piper Jaffray Buy   Dec 07, '15   46.91  57.00  Dec 07, '16  -8.36% 
Timothy Mchugh William Blair & Company, L.L.C. Buy   Sep 09, '15   35.59    Sep 09, '16  6.91% 
Paul Ginocchio Deutsche Bank Securities Buy   May 26, '15   37.74  43.00  May 26, '16  13.94% 
Paul Ginocchio Deutsche Bank Securities Buy   Feb 19, '15   38.40  40.00  Feb 19, '16  4.17% 
Randle Reece Avondale Partners LLC Buy   Oct 15, '14   28.78    Oct 15, '15  32.28% 
Edward Caso Wells Fargo Securities, Llc Buy   Mar 20, '14   38.76    Mar 20, '15  -0.23% 
Paul Ginocchio Deutsche Bank Securities Buy   Feb 03, '14   29.81    Feb 03, '15  19.56% 
Jeffrey Silber BMO Capital Markets Buy   Oct 24, '13   33.05  38.00  Oct 24, '14  14.98% 
Tobey Sommer Suntrust Robinson Humphrey Buy   Jul 16, '13   29.51  37.00  Jul 16, '14  25.38% 
Jeffrey Silber BMO Capital Markets Buy   Jul 10, '13   29.63  33.00  Jul 10, '14  20.89% 
< previous12